Fig. 1From: Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetesStudy flow chart. STEMI ST-segment elevation myocardial infarction, PCI percutaneous coronary intervention, PCSK9 proprotein convertase subtilisin/kexin type 9, DM diabetes mellitus, Non-DM non-diabetes mellitusBack to article page